arrow_back Trending Legislation
Share share

Boosting Lung Cancer Research and Screening Access for Women and Underserved Groups.

This law mandates a federal review of lung cancer research, focusing specifically on women and populations with limited access to healthcare. The goal is to develop a national strategy to expand screening access, improve early detection, and launch public awareness campaigns. Citizens can expect future improvements in preventive services and knowledge regarding lung cancer, particularly benefiting currently overlooked communities.
Key points
Requires a comprehensive interagency review of lung cancer research status in women and underserved populations.
Mandates the development of a national strategy to expand access to lung cancer screenings and early detection.
Calls for a national public education campaign emphasizing early detection and prevention.
article Official text account_balance Process page notifications_active Track this Bill
Previous:
Placed on Calendar
arrow_forward_ios
gavel
Status:
Passed House
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Women and Lung Cancer Research and Preventive Services Act of 2025
Print number: HR 2319
Sponsor: Rep. Boyle, Brendan F. [D-PA-2]
Process start date: 2025-03-25
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Boosting Lung Cancer Research and Screening Access for Women and Underserved Groups.

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is HR 2319.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-03-25.

What are the main provisions?

Key points include:

  • Requires a comprehensive interagency review of lung cancer research status in women and underserved populations.
  • Mandates the development of a national strategy to expand access to lung cancer screenings and early detection.
  • Calls for a national public education campaign emphasizing early detection and prevention.

What is the specific legal status?

The current status is Passed House.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Boyle, Brendan F. [D-PA-2].

What is the latest detailed status?

The latest detailed status is: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H3020)

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-22.

Analysis and Potential Impact of HR 2319

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health